Pharmaceuticals 2010, 3(6), 1873-1886; doi:10.3390/ph3061873

Cannabinoids and Viral Infections

Department of Biology, Center for Neural Science, NYU Cancer Institute and Department of Microbiology, New York University, 100 Washington Square East, New York, NY, 10003, USA
Received: 21 May 2010; in revised form: 28 May 2010 / Accepted: 9 June 2010 / Published: 9 June 2010
(This article belongs to the Special Issue Cannabinoids)
PDF Full-text Download PDF Full-Text [127 KB, uploaded 9 June 2010 16:38 CEST]
Abstract: Exogenous cannabinoids or receptor antagonists may influence many cellular and systemic host responses. The anti-inflammatory activity of cannabinoids may compromise host inflammatory responses to acute viral infections, but may be beneficial in persistent infections. In neurons, where innate antiviral/pro-resolution responses include the activation of NOS-1, inhibition of Ca2+ activity by cannabinoids, increased viral replication and disease. This review examines the effect(s) of cannabinoids and their antagonists in viral infections.
Keywords: pathogens; virus infection; immunomodulation; inflammation

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Reiss, C.S. Cannabinoids and Viral Infections. Pharmaceuticals 2010, 3, 1873-1886.

AMA Style

Reiss CS. Cannabinoids and Viral Infections. Pharmaceuticals. 2010; 3(6):1873-1886.

Chicago/Turabian Style

Reiss, Carol Shoshkes. 2010. "Cannabinoids and Viral Infections." Pharmaceuticals 3, no. 6: 1873-1886.

Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert